NuVasive Inc. (NUVA)
NASDAQ: NUVA
· Real-Time Price · USD
39.75
-0.91 (-2.24%)
At close: Aug 31, 2023, 8:00 PM
-2.24% (1D)
| Bid | n/a |
| Market Cap | 2.08B |
| Revenue (ttm) | 1.23B |
| Net Income (ttm) | 28.45M |
| EPS (ttm) | 0.53 |
| PE Ratio (ttm) | 75 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 30,593,998 |
| Avg. Volume (20D) | 1,414,938 |
| Open | 40.62 |
| Previous Close | 40.66 |
| Day's Range | 39.51 - 40.96 |
| 52-Week Range | 35.17 - 49.53 |
| Beta | 1.07 |
About NUVA
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant...
Industry Medical - Devices
Sector Healthcare
IPO Date May 13, 2004
Employees 3,000
Stock Exchange NASDAQ
Ticker Symbol NUVA
Website https://www.nuvasive.com